To further validate the findings described above, the regulatory effects of iASPP(295–828) on apoptosis were also examined in the breast cancer cell line SK-BR3, in which NF-κBp65 has been reported to be constitutively active and p53 has been inactivated by mutation [31, 32]. Here, TP53 is linked to breast carcinoma.